INTRAVENOUS VITAMIN C (IVC) TREATMENT OUTCOME OF COVID 19 PATIENTS ADMITTED IN HOSPITAL: A SYSTEMATIC REVIEW
Downloads
Background: Coronavirus disease 2019 (COVID-19) is still becoming a problem in several countries with the emergence of new variants with the latest variant named Omicron. Studies show that patients with COVID-19 tend to have Acute Respiratory Distress Syndrome (ARDS) because of high pro-inflammatory cytokines and chemokines levels. Since its role as an antiviral agent, anti-cytokine, immunomodulator, antioxidant and has potential effect in maintaining body functions, vitamin C can be used as one of therapy. There is still arguable about giving treatment of COVID-19 patients with Intravenous Vitamin C (IVC). Previous research has not been discussed related to accelerating recovery and decreasing mortality. Purpose: To identify the impact of IVC intervention given to COVID-19 patients admitted in hospital by reviewing clinical outcomes particularly on complexity or mortality. Review: Literature information was sourced from PubMed, ScienceDirect, and Google Scholar databases through keywords to retrieve inclusion criteria published during 2019-2021. Result: We found that IVC influenced inflammatory biomarkers such as CRP, d-dimer, ferritin, and several inflammatory cytokines, mortality, length of stay, oxygenation, organ and immune system function but showed no significant difference between the control group. Conclusion: IVC treatment might be an essential adjuvant therapy in the aggravation of mild, severe, and critical COVID-19 patients, but did not understate complexity or mortality. Hence, further research and evaluation in clinical trials are needed.
Bae, M., Kim, H., 2022. Mini-Review on The Roles of Vitamin C, Vitamin D, and Selenium in The Immune System against COVID-19. Molecules Vol. 25(22), Pp. 5346.
Capone, S., Abramyan, S., Ross, B., Rosenberg, J., Zeibeq, J., Vasudevan, V., Samad, R., Gerolemou, L., Pinelis, E., Gasperino, J., Orsini, J., 2020. Characterization of Critically III COVID-19 Patients at a Brooklyn Safety-Net Hospital. Cureus Vol. 12(8), Pp. e9809.
Chen, W., Zheng, K.I., Liu, S., Yan, Z., Xu, C., Qiao, Z., 2020. Plasma CRP Level is Positively Associated with The Severity of COVID-19. Ann. Clin. Microbiol. Antimicrob. Vol. 19(1), Pp. 18.
Cheng, R.Z., 2020. Can Early and High Intravenous Dose of Vitamin C Prevent and Treat Coronavirus Disease 2019 (COVID-19)? Med Drug Discov. Vol. 5, Pp. 100028.
Chiscano-Camon, L., Ruiz-Rodriguez, J.C., Ruiz-Sanmartin, A., Roca, O., Ferrer, R., 2020. Vitamin C Levels in Patients with SARS-CoV-2-Associated Acute Respiratory Distress Syndrome. Crit. Care Vol. 522.
Coperchini, F., Chiovato, L., Croce, L., Magri, F., Rotondi, M., 2020. The Cytokine Storm in COVID-19:An Overview of The Involvement of The Chemokine/Chemokine-Receptor System. Cytokine Growth Factor Rev. Vol. 53, Pp. 25-32.
Darban, M., Bagheri, F.M.M.M., Gohari, A., Kiani, A., Emadi, A., Lavvaf, S., Bagheri, B., 2021. Efficacy of High Dose Vitamin C, Melatonin and Zinc in Iranian Patients with Acute Respiratory Syndrome due to Coronavirus Infection: A Pilot Randomized Trial. J. Cell. Mol. Anesth. Vol. 6(2), Pp. 164-167.
Deng, Y., Liu, W., Liu, K., Fang, Y.-Y., Shang, J., Zhou, L., Wang, K., Leng, F., Wei, S., Chen, L., Liu, H.-G., 2020. Clinical Characteristics of Fatal and Recovered Cases of Coronavirus Disease 2019 in Wuhan, China: A Retrospective Study. Chin. Med. J. (Engl). Vol. 133(1, Pp. 1261-1267.
Erol, N., Saglam, L., Saglam, Y.S., Erol, H.S., Altun, S., Aktas, M.S., Halici, M.B., 2019. The Protection Potential ofAntioxidant Vitamins Against Acute RespiratoryDistress Syndrome: A Rat Trial. Inflammation. Vol. 42(5), Pp. 1585-1594.
FDA, 2020. FDA Cautions against Use of Hydroxychloroquine or Chloroquine for COVID-19 Outside of The Hospital Setting or A Clinical Trial due to Risk of Heart Rhythm Problems. Drug Saf. Availab. URL https://www.fda.gov/drugs/drug-safety-and-availability/fda-cautions-against-use-hydroxychloroquine-or-chloroquine-covid-19-outside-hospital-setting-or
Fontana, F., Cazzato, S., Giovanella, S., Ballestri, M., Leonelli, M., Mori, G., Alfano, G., Ligabue, G., Magistroni, R., Cenacchi, G., Antoniotti, R., Bonucchi, D., Cappelli, G., 2020. Oxalate Nephropathy Caused by Excessive Vitamin C Administration in 2 Patients with COVID-19. Kidney Int Reports Vol. 5(10), Pp. 1815-1822.
Gao, D., Xu, M., Wang, G., Lv, J., Ma, X., Guo, Y., Zhang, D., Yang, H., Jiang, W., Deng, F., Xia, G., Lu, Z., Lv, L., Gong, S., 2021. The Efficiency and Safety of High-Dose Vitamin C in Patients with COVID-19: A Retrospective Ccohort Study. Aging (Albany NY) Vol. 13(5), Pp. 7020-7034.
Gu, Y., Wang, D., Chen, C., Lu, W., Liu, H., Lv, T., Song, Y., Zhang, F., 2021. PaO2/FiO2 and IL-6 are Risk Factors of Mortality for Intensive Care COVID-19 Patients. Sci. Rep. Vol. 11(1), Pp. 7334.
Herold, T., Jurinovic, V., Arnreich, C., Lipworth, B.J., Hellmuth, J.C., Bergwelt-Baildon, M. von, Klein, M., Weinberger, T., 2020. Elevated Levels of IL-6 and CRP Predict The Need for Mechanical Ventilation in COVID-19. J. Allergy Clin. Immunol. Vol. 146(1), Pp. 128-136.
Hiedra, R., Lo, K.B., Elbashabsheh, M., Gul, F., Wright, R.M., Albano, J., Azmaiparashvili, Z., Aponte,G.P., 2020. The Use of IV Vitamin C for Patientswith COVID-19: A Single Center ObservationalStudy. Expert Rev. Anti. Infect. Ther. Vol. 18(12),Pp. 1259-1261.
Hu, R., Han, C., Pei, S., Yin, M., Chen, X., 2020. Procalcitonin Levels in COVID-19 Patients. Int J Antimicrob Agents Vol. 56(2), Pp. 106051.
Hui, L.L., Nelson, E.A.S., Lin, S.L., Zhao, J. V, 2022. The Role of Vitamin C in Pneumonia and COVID-19 Infection in Adults with European Ancestry: a Mendelian Randomisation Study. Eur. J. Clin. Nutr. Vol. 76(4), Pp. 588-591.
Kumar, S., Thambiraja, T.S., Karuppanan, K., Subramaniam, G., 2021. Omicron and Delta Variant of SARS-CoV-2: A Comparative Computational Study of Spike protein. J. Med. Virol. Vol. 94(4), Pp. 1641-1649.
Kumari, P., Dembra, S., Dembra, P., Bhawna, F., Gul, A., Ali, B., Sohail, H., Kumar, B., Memon, M.K., Rizwan, A., 2020. The Role of Vitamin C as Adjuvant Therapy in COVID-19. Cureus Vol. 12(11), Pp. 1-4.
Langlois, P.L., Manzanares, W., Adhikari, N.K.J., Lamontagne, F., Stoppe, C., Hill, A., Heyland, D.K., 2019. Vitamin C Administration to the Critically Ill: A Systematic Review and Meta-Analysis. J. Parenter. Enter. Nutr. 43, 335–346.
Li, M., Ching, T.H., Hipple, C., Lopez, R., Sahibzada, A., Rahman, H., 2021. Use of Intravenous Vitamin C in Critically Ill Patients with COVID-19 Infection. J. Pharm. Pract. Vol. 36(1), Pp. 60-66.
Mahmoodpoor, A., Shadvar, K., Sanaie, S., Hadipoor, M.R., Pourmoghaddam, M.A., Saghaleini, S.H.,2021. Effect of Vitamin C on Mortality of CriticallyIll Patients with Severe Pneumonia in IntensiveCare Unit: A Preliminary Study. BMC Infect. Dis. Dis Vol.21(1), Pp. 616.
Marik, P.E., Kory, P., Varon, J., Iglesias, J., Meduri, G.U., 2021. MATH+ Protocol for The Treatment of SARS-CoV-2 Infection: The Scientific Rationale. Expert Rev. Anti. Infect. Ther. Vol. 19(2), Pp. 129-135.
Ming, D.K., Myall, A.C., Hernandez, B., WeiíŸe, A.Y., Peach, R.L., Barahona, M., Rawson, T.M., Holmes, A.H., 2021. Informing Antimicrobial Managementin The Context of COVID-19: Understanding TheLongitudinal Dynamics of C-Reactive Protein andProcalcitonin. BMC Infect. Dis. Vol. 21(93), Pp. 1-7.
Miranda-Massari, J.R., Toro, A.P., Loh, D., Rodriguez, J.R., Borges, R.M., Marcial-Vega, V., Olalde, J., Berdiel, M.J., Riordan, N.H., Martinez, J.M., Gil, A., Gonzalez,M.J., 2021. The Effects of Vitamin C on the Multiple Pathophysiological Stages of COVID-19. Life 11,Pp. 1341.
Ozgunay, S.E., Ceylan, Ä°., Okmen, K., Sayan, H.E., Eminoglu, S., Karasu, D., Yavuz, S., 2021. The Use of Vitamin C in The Intensive Care Unit during The COVID-19 Pandemic. Eur. Res. J. Vol. 7(4), Pp. 425-431.
Peng, X., Ouyang, J., Isnard, S., Lin, J., Fombuena, B., Zhu, B., Routy, J.-P., 2020. Sharing CD4+ T Cell Loss: When COVID-19 and HIV Collide on Immune System. Front Immunol. Front. Immunol. Vol. 11, Pp. 1-11.
Riviello, E.D., Kiviri, W., Twagirumugabe, T., Mueller, A., Banner-Goodspeed, V.M., Officer, L., Novack, V., Mutumwinka, M., Talmor, D.S., Fowler, R.A., 2016. Hospital Incidence and Outcomes of The Acute Respiratory Distress Syndrome using The Kigali Modification of The Berlin Definition. Am. J. Respir. Crit. Care Med. Vol.193(1), Pp. 52-59.
Sanders, J.M., Monogue, M.L., Jodlowsk, T.Z., 2020. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review. JAMA Netw. Open. Vol. 323(1), Pp. 1824-1836.
Scholz, S.S., Borgstedt, R., Ebeling, N., Menzel, L.C., Jansen, G., Rehberg, S., 2021. Mortality in Septic Patients Treated with Vitamin C: A Systematic Meta-Analysis. Crit. Care Vol. 25(1), Pp. 17.
Sharifpour, M., Rangaraju, S., Liu, M., Alabyad, D., Nahab, F.B., Creel-Bulos, C.M., Jabaley, C.S., 2020. C-Reactive Protein as A Prognostic Indicator in Hospitalized patients with COVID-19. PLoS One. Vol.15, Pp. 1–10.
Siahkali, S.J.M., Zarezade, B., Koolaji, S., Alinaghi, S.A.S., Zendehdel, A., Tabarestani, M., Moghadam, E.S., Abbasian, L., Dehghan, S.A., Manshadi, Salehi, M., Hasannezhad, M., Ghaderkhani, S., Meidani, M., Salahshour, F., Jafari, F., Manafi, N., Ghiasvand, F., 2021. Safety and Effectiveness of High-Dose Vitamin C in Patients with COVID-19: A Randomized Open-Label Clinical Trial. Eur. J. Med. Res. Vol. 26(1), Pp. 20.
Sumantri, A.F., Bashari, M.H., Tadjoedin, H., Atik, N., 2022. Risk of Coronavirus Disease 2019 (COVID-19) infection on leukemia patients : basic science to clinical aspect. SPER Publ. Vol.12, Pp. 38–45.
Suna, K., Melahat, U.S., Murat, Y., Figen, O.E., Ayperi, O., 2022. Effect of High-Dose Intravenous Vitamin C on Prognosis in Patients with SARS-CoV-2 Pneumonia. Med. Clin. Vol. 158(8), Pp. 356-360.
Thomas, S., Patel, D., Bittel, B., Wolski, K., Wang, Q., Kumar, A., Il'Giovine, Z.J., Mehra, R., McWilliams, C., Nissen, S.E., Desai, M.Y., 2021. Effect of High-Dose Zinc and Ascorbic Acid Supplementation vs Usual Care on Symptom Length and Reduction among Ambulatory Patients with SARS-CoV-2 Infection: The COVID A to Z Randomized Clinical Trial. JAMA Netw. Open Vol. 4(2), Pp. e210369.
Tomasa-Irriguible, T.M., Bielsa-Berrocal, L., 2021. COVID-19: Up to 82% Critically Ill Patients had Low Vitamin C Values. Nutr. J. Vol. 20(1), Pp. 6.
WHO, 2020. Coronavirus Disease 2019 (COVID-19) Situation Report–32. URL https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200221-sitrep-32-covid-19.pdf
WHO, 2021. Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern. World Heal. Organ. URL https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern#:~:text=Based on the evidence presented,as a VOC%2C named Omicron. (accessed 1.19.22).
Xia, G., Fan, D., He, Y., Zhu, Y., Zheng, Q., 2021. High-Dose Intravenous Vitamin C Attenuates Hyperinflammation in Severe Coronavirus Disease 2019. Nutrition Vol. 91, Pp. 111405.
Zaim, S., Chong, J.H., Sankaranarayanan, V., Harky, A., 2020. COVID-19 and Multiorgan Response. Curr Probl Cardiol Vol. 45(8), Pp. 100618.
Zhang, J., Rao, X., Li, Y., Zhu, Y., Liu, F., Guo, G., Luo, G., Meng, Z., Backer, D. De, Xiang, H., Peng, Z., 2021. Pilot Trial of High-Dose Vitamin C in Critically Ill COVID-19 Patients. Ann. Intensive Care Vol.11(5), Pp. 3-14.
Zhang, M., Jativa, D.F., 2018. Vitamin C Supplementation in The Critically Ill: A Systematic Review and Meta-Analysis. SAGE Open Med. Vol.6(19).
Zhao, B., Ling, Y., Li, J., Peng, Y., Huang, J., Wang, Y., Qu, H., Gao, Y., Li, Y., Hu, B., Lu, S., Lu, H., Zhang, W., Mao, E., 2021a. Beneficial Aspects of High Dose Intravenous Vitamin C on Patients with COVID-19 Pneumonia in Severe Condition: A Retrospective Case Series study. Ann. Palliat. Med. Vol. 10(2), Pp. 1599-1609.
Zhao, B., Liu, M., Liu, P., Peng, Y., Huang, J., Li, M., Wang, Y., Xu, L.L., Sun, S., Qi, X., Ling, Y., Li, J., Zhang, W., Mao, E., Qu, J., 2021b. High Dose Intravenous Vitamin C for Preventing The Disease Aggravation of Moderate COVID-19 Pneumonia. A Retrospective Propensity Matched Before-After Study. Front. Pharmacol. Vol.12(12), Pp. 1–9.
Zheng, S., Chen, Q., Jiang, H., Guo, C., Luo, J., Li, S., et al., 2021. No Significant Benefit of Moderate-Dose Vitamin C on Severe COVID-19 Cases. Open Med. Vol.16, Pp.1403–14
Copyright (c) 2023 Journal of Vocational Health Studies
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
- The authors agree to transfer the transfer copyright of the article to the Journal of Vocational Health Studies (JVHS) effective if and when the paper is accepted for publication.
- Legal formal aspect of journal publication accessibility refers to Creative Commons Attribution-NonCommercial-ShareAlike (CC BY-NC-SA), implies that publication can be used for non-commercial purposes in its original form.
- Every publications (printed/electronic) are open access for educational purposes, research, and library. Other that the aims mentioned above, editorial board is not responsible for copyright violation.
Journal of Vocational Health Studies is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License
